Metabolism - Clinical and Experimental
Volume 46, Issue 6 , Pages 605-610, June 1997

Very-low-density lipoprotein subfraction composition and metabolism by adipose tissue

  • Rachel M. Fisher

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Rachel M. Fisher, D Phil, Division of Cardiovascular Genetics, Department of Medicine, University College London Medical School, Rayne Institute, London, WC1E 6JJ UK.
    • Endocrine and Atherosclerosis Research Units, Mayo Clinic, Rochester, MN, USA
    • Oxford Lipid Metabolism Group, Radcliffe Infirmary, Oxford, USA
    • Department of Medicine, University College London Medical School, Rayne Institute, London, UK
  • ,
  • John M. Miles

      Affiliations

    • Endocrine and Atherosclerosis Research Units, Mayo Clinic, Rochester, MN, USA
    • Oxford Lipid Metabolism Group, Radcliffe Infirmary, Oxford, USA
    • Department of Medicine, University College London Medical School, Rayne Institute, London, UK
  • ,
  • Bruce A. Kottke

      Affiliations

    • Endocrine and Atherosclerosis Research Units, Mayo Clinic, Rochester, MN, USA
    • Oxford Lipid Metabolism Group, Radcliffe Infirmary, Oxford, USA
    • Department of Medicine, University College London Medical School, Rayne Institute, London, UK
  • ,
  • Keith N. Frayn

      Affiliations

    • Endocrine and Atherosclerosis Research Units, Mayo Clinic, Rochester, MN, USA
    • Oxford Lipid Metabolism Group, Radcliffe Infirmary, Oxford, USA
    • Department of Medicine, University College London Medical School, Rayne Institute, London, UK
  • ,
  • Simon W. Coppack

      Affiliations

    • Endocrine and Atherosclerosis Research Units, Mayo Clinic, Rochester, MN, USA
    • Oxford Lipid Metabolism Group, Radcliffe Infirmary, Oxford, USA
    • Department of Medicine, University College London Medical School, Rayne Institute, London, UK

Received 2 September 1995; accepted 22 December 1996.

Abstract 

Lipoprotein lipase (LPL) plays a pivotal role in very—low-density lipoprotein (VLDL) metabolism. Within the circulation, the VLDL population is heterogeneous with respect to both size and composition. Several studies have investigated the action of LPL in vitro on different VLDL subfractions, but little is known of the action of LPL in vivo. To investigate this, arterial and adipose tissue venous plasma samples were obtained from 16 normal male healthy volunteers (aged 24.4 ± 1.8 years; body mass index, 23.5 ± 0.7 kg · m−2) following an overnight fast. VLDL subfractions were isolated (VLDL1 of Sf 60 to 400 and VLDL2 of Sf 20 to 60) and characterized in terms of triacylglycerol (TAG) and apolipoprotein (apo) B, E, CI, CII, and CIII content. The apolipoprotein content of VLDL1 differed from that of VLDL2: the VLDL2 fraction contained significantly more apo B (0.018 ± 0.004 v 0.011 ± 0.003 μmol · L−1, P = .001) but the ratios of TAG:apo B and apo CI:B, CII:B, and CIII:B were significantly higher in VLDL1 (48,200 ± 7,960 v 13,860 ± 2,420, 22.7 ± 5.5 v 12.5 ± 2.2, 45.0 ± 6.3 v 14.9 ± 2.0, and 0.434 ± 0.077 v 0.357 ± 0.054, respectively, molar ratios, all P < .05). The venous blood draining an adipose tissue depot contained less VLDL1-TAG than arterial blood (328 ± 68 v 381 ± 83 μmol · L−1, respectively, P < .01), whereas VLDL2-TAG exhibited an opposite tendency (199 ± 46 v 172 ± 31 μmol · L−1, NS). Concentrations of VLDL1-apo B, -apo CII, and -apo CIII were significantly less in adipose tissue venous blood compared with arterial blood (0.011 ± 0.004 v 0.013 ± 0.004, 0.38 ± 0.08 v 0.43 ± 0.10, and 1.33 ± 0.35 v 1.58 ± 0.38 μmol · L−1, respectively, all P < .05). These studies demonstrated novel differences in VLDL1 and VLDL2 in terms of composition and metabolism by human adipose tissue LPL in vivo.

No full text is available. To read the body of this article, please view the PDF online.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported in part by grants from the US Public Health Service (DK38092 and RR00585) and a British Heart Foundation Research Studentship (R.M.F.).

PII: S0026-0495(97)90001-9

Metabolism - Clinical and Experimental
Volume 46, Issue 6 , Pages 605-610, June 1997